Personalized T-cell Therapy for Solid Tumours: Novel Platforms to Create Patient-Specific TCR Therapies Targeting Neoantigens
Time: 9:20 am
day: Day One
Details:
- Uncovering NEOXpress Platform to identify, clone and express neoantigens for personalized therapies
- Highlighting TCXpress platform to identify effective neoantigen targeting TCRs
- Showcasing a quick and cost effective process to produce TCR therapies against neoantigens
